EX-1.1
from S-1/A
28 pages
The Following Will Confirm Our Agreement Relating to the Proposed Rights Offering (The “Rights Offering”) to Be Undertaken by AIM ImmunoTech Inc., a Delaware Corporation (The “Company”), Pursuant to Which the Company Will Distribute to Holders of Record of Its Common Stock, Par Value $0.001 Per Share (The “Common Stock”), and to Holders of Certain Outstanding Options and Warrants of the Company (The “Participating Securities”) Subscription Rights (The “Rights”) to Subscribe for Up to an Aggregate of 12,000 Units (The “Units”), Each Unit Consisting of One Share of Series G Convertible Preferred Stock (The “Rights Shares”), 1,666 Warrants, With Each Warrant Representing the Right to Purchase One Share of Common Stock (The “Rights Warrants” and the Rights Shares, the Rights Warrants and the Shares of Common Stock Issuable Upon Conversion of the Rights Shares and Exercise of the Rights Warrants, the “Securities”), at a Subscription Price of $1,000 Per Unit in Cash (The “Subscription Price”). 1. the Rights Offering
12/34/56
EX-1.1
from 8-K
8 pages
1. Securities. the Term “Securities”, as Used Herein, Shall Be Defined as and Include the Issuance Of, or Reference To, Client’s Common Stock, Debt, Equity or Debt Instruments Convertible Into Client’s Common Stock, Units, Warrants, Additional Investment Rights, Block Trade Transactions or the Exercise of Warrants or Options. 2. Transaction(s). the Term “Transaction” or “Transactions”, as Used Herein, Shall Be Defined as and Include the Sale, Private or Public Offering, Placement, Pledge or Issuance of Client’s Securities and/or Securities Owned by the Officers, Directors and/or Affiliates (“Insiders”) of Client, to Any Institutional and/or Accredited Investor(s). the Actual Terms and Structure of Each Transaction Will Depend on Market Conditions and Will Be Subject to Negotiation Between the Client, Ascendiant, and Prospective Investors. 3. Investor(s) the Term “Investor” or “Investors”, as Used Herein, Shall Be Defined as and Include Any Natural Persons, Corporations, Limited Liability Companies, Partnerships, Unincorporated Businesses, Sole Proprietorships and Similar Entities, and Any and All Related Affiliates for Which the Investors Maintain Direct or Indirect Control, That Are Listed in an Exhibit B to This Agreement
12/34/56
